BC1618

CAS : 2222094-18-8

Ref. 3D-XND09418

Informations sur le produit

• Nom: BC1618
• CAS: 2222094-18-8

Description

BC1618 is a peptide that activates the GABA(A) receptor. It has been shown to be a high-potency activator of the GABA(A) receptor, with an EC50 of 2.5 nM in recombinant cell lines. BC1618 has also been shown to inhibit ligand-gated ion channels and produce long-lasting changes in cell membrane potentials. In addition, BC1618 is a potent inhibitor of the voltage-dependent calcium channel (VDCC) current with an IC50 of 100 nM.

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a drug used for tuberculosis treatment that inhibits bacterial growth by binding to DNA dependent RNA polymerase and prevents transcription and replication. The high frequency of human activity has been shown using patch clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 415.4 g/mol
• Formule: C₂₄H₂₄F₃NO₂
• Degré de pureté: Min. 95%